Jentzer Jacob C, Drakos Stavros G, Selzman Craig H, Owyang Clark, Teran Felipe, Tonna Joseph E
Department of Cardiovascular Medicine Mayo Clinic Rochester MN USA.
Division of Cardiovascular Medicine and Nora Eccles Harrison Cardiovascular Research Training Institute University of Utah Salt Lake City UT USA.
J Am Heart Assoc. 2024 Feb 6;13(3):e032288. doi: 10.1161/JAHA.123.032288. Epub 2024 Jan 19.
Venoarterial extracorporeal membrane oxygenation (ECMO) provides full hemodynamic support for patients with cardiogenic shock, but optimal timing of ECMO initiation remains uncertain. We sought to determine whether earlier initiation of ECMO is associated with improved survival in cardiogenic shock.
We analyzed adult patients with cardiogenic shock who received venoarterial ECMO from the international Extracorporeal Life Support Organization (ELSO) registry from 2009 to 2019, excluding those cannulated following an operation. Multivariable logistic regression evaluated the association between time from admission to ECMO initiation and in-hospital death. Among 8619 patients (median, 56.7 [range, 44.8-65.6] years; 33.5% women), the median duration from admission to ECMO initiation was 14 (5-32) hours. Patients who had ECMO initiated within 24 hours (n=5882 [68.2%]) differed from those who had ECMO initiated after 24 hours, with younger age, more preceding cardiac arrest, and worse acidosis. After multivariable adjustment, patients with ECMO initiated >24 hours after admission had higher risk of in-hospital death (adjusted odds ratio, 1.20 [95% CI, 1.06-1.36]; =0.004). Each 12-hour increase in the time from admission to ECMO initiation was incrementally associated with higher adjusted in-hospital mortality rate (adjusted odds ratio, 1.06 [95% CI, 1.03-1.10]; <0.001). The association between longer time to ECMO and worse outcomes appeared stronger in patients with lower shock severity.
Longer delays from admission to ECMO initiation were associated with higher a mortality rate in a large-scale, international registry. Our analysis supports optimization of door-to-support time and the avoidance of inappropriately delayed ECMO initiation.
静脉-动脉体外膜肺氧合(ECMO)为心源性休克患者提供全面的血流动力学支持,但ECMO启动的最佳时机仍不确定。我们试图确定更早启动ECMO是否与心源性休克患者生存率的提高相关。
我们分析了2009年至2019年从国际体外生命支持组织(ELSO)登记处接受静脉-动脉ECMO的成年心源性休克患者,排除术后插管的患者。多变量逻辑回归评估了从入院到启动ECMO的时间与院内死亡之间的关联。在8619例患者中(中位数为56.7岁[范围为44.8 - 65.6岁];33.5%为女性),从入院到启动ECMO的中位时间为14(5 - 32)小时。在24小时内启动ECMO的患者(n = 5882例[68.2%])与在24小时后启动ECMO的患者不同,前者年龄更小,心脏骤停史更多,酸中毒更严重。经过多变量调整后,入院后>24小时启动ECMO的患者院内死亡风险更高(调整后的优势比为1.20[95%置信区间为1.06 - 1.36];P = 0.004)。从入院到启动ECMO的时间每增加12小时,调整后的院内死亡率就会相应增加(调整后的优势比为1.06[95%置信区间为1.03 - 1.10];P < 0.001)。在休克严重程度较低的患者中,从入院到ECMO的时间越长与预后越差之间的关联似乎更强。
在一个大规模的国际登记处中,从入院到启动ECMO的延迟时间越长与死亡率越高相关。我们的分析支持优化从入院到获得支持的时间,并避免不适当延迟启动ECMO。